News

MedUni Vienna: New insights into cellular processes after a stroke

Valneva and LimmaTech Enter into a Strategic Partnership to Accelerate the Development of the World’s Most Clinically Advanced Tetravalent Shigella Vaccine Candidate

Sandia National Laboratories acquire second Lithoz CeraFab printer to ramp up their R&D scale of additively manufactured ceramic parts

University of Vienna: The Next Generation of RNA Chips

ÖGP: Welt-Lungenkrebstag: „Zukunftsmusik“ spielt im Hier und Jetzt

MedUni Vienna: Gastric cancer - Biomarkers identified to predict the risk of relapse

MedUni Vienna: Climate change and "new" allergy triggers extend pollen season

Wiener Gesundheitsverbund und die Vinzenz Gruppe Wien setzen auf digitalen Bildaustausch

Pharmig: Lebenswichtig: Blutplasmaspenden werden dringend benötigt

Cancer Mission Lab des Open Innovation in Science Center der LBG: Förderempfehlung für drei innovative Projekte

UpNano: Novel process for 3D-printing macro-sized fused silica parts with hi-res features

MedUni Vienna: Kidney transplantation: Combined cell therapy reduces donor-specific immune response

Caritas Pflege: Ausschreibung für Anbieter*innen von Telemedizin/Telemedizinplattformen

CEPI Expands Partnership with Valneva with a $41.3 Million Grant to Support Broader Access to the World’s First Chikungunya Vaccine

HOOKIPA Pharma Announces Leadership Changes to Intensify Focus on HB-200

Matthias Gauly zum Rektor der Veterinärmedizinischen Universität Wien gewählt

Nachhaltige Arzneimittelproduktion bei Takeda

First half of 2024: Boehringer Ingelheim progresses pipeline at pace and reaches major milestones

MADx: Präzise Allergietests für bessere Patientenbetreuung

invIOs: We are proud to announce that invIOs has selected INV501’s lead candidate to progress into IND-enabling studies in glioblastoma and melanoma.